Published in BMC Cancer on January 17, 2012
Vascular endothelial growth factor receptor 3 controls neural stem cell activation in mice and humans. Cell Rep (2015) 0.92
Epigenetic deregulation in pediatric acute lymphoblastic leukemia. Epigenetics (2014) 0.86
DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia. PLoS One (2012) 0.83
Variable promoter methylation contributes to differential expression of key genes in human placenta-derived venous and arterial endothelial cells. BMC Genomics (2013) 0.82
Ectopic expression of homeobox gene NKX2-1 in diffuse large B-cell lymphoma is mediated by aberrant chromatin modifications. PLoS One (2013) 0.77
The identification of age-associated cancer markers by an integrative analysis of dynamic DNA methylation changes. Sci Rep (2016) 0.76
DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival. Oncotarget (2016) 0.75
DNA methylation patterns and epigenetic memory. Genes Dev (2002) 33.83
Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med (2003) 18.04
Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst (1995) 2.44
Polycomb group complexes--many combinations, many functions. Trends Cell Biol (2009) 2.36
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest (2000) 2.08
Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci U S A (2001) 1.90
Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J Biol Chem (1995) 1.78
Expression of vascular endothelial growth factor receptors in human prostate cancer. Urology (1999) 1.71
Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway. Carcinogenesis (2009) 1.65
Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. J Pathol (1998) 1.62
Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer (2005) 1.62
Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur J Immunol (2002) 1.57
Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood (2009) 1.50
Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood (2002) 1.47
Vascular endothelial growth factor receptor-2 in breast cancer. Biochim Biophys Acta (2010) 1.32
SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines. J Hematol Oncol (2009) 1.09
Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2. Infect Immun (1999) 1.07
Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia. Leukemia (1997) 1.03
The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation. Epigenetics (2009) 1.01
Activation of nuclear factor-kappaB in macrophages by mycoplasmal lipopeptides. Eur J Immunol (1998) 0.96
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas. Leuk Lymphoma (2009) 0.93
Signaling pathways induced by vascular endothelial growth factor (review). Int J Mol Med (2000) 0.93
DNA methylation, induced by beta-carotene and arachidonic acid, plays a regulatory role in the pro-angiogenic VEGF-receptor (KDR) gene expression in endothelial cells. J Physiol Pharmacol (2009) 0.86
Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas. Leuk Lymphoma (2007) 0.86
Expression of vascular endothelial growth factor and its receptors during lung carcinogenesis by N-nitrosobis(2-hydroxypropyl)amine in rats. Mol Carcinog (1999) 0.82
Cytokine response profiles of human myeloid factor-dependent leukemia cell lines. Leukemia (1997) 0.81
Expression of vascular endothelial growth factor receptor 3 and Tie1 tyrosine kinase receptor on acute leukemia cells. Pediatr Blood Cancer (2007) 0.78
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet (2010) 7.96
The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet (2013) 3.43
Check your cultures! A list of cross-contaminated or misidentified cell lines. Int J Cancer (2010) 3.04
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med (2009) 2.39
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet (2012) 2.07
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood (2008) 1.97
Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma. BMC Cancer (2010) 1.55
Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphoma. Leuk Lymphoma (2010) 1.54
Mix-ups and mycoplasma: the enemies within. Leuk Res (2002) 1.51
One falsehood leads easily to another. Int J Cancer (2008) 1.49
Comparative PCR analysis for detection of mycoplasma infections in continuous cell lines. In Vitro Cell Dev Biol Anim (2002) 1.45
Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma. Leuk Res (2003) 1.44
BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance. J Hematol Oncol (2011) 1.43
Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line. Genes Chromosomes Cancer (2013) 1.42
Establishment of novel B-cell precursor leukemia sister cell lines NALM-36 and NALM-37: shift of immunoglobulin phenotype to double light chain positive B-cell. Leuk Res (2002) 1.37
Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer. Int J Cancer (2002) 1.34
Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1. Cancer Res (2007) 1.34
Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines. Int J Cancer (2002) 1.26
Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest Ophthalmol Vis Sci (2002) 1.26
The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). Cancer Res (2003) 1.25
Cortactin deficiency is associated with reduced neutrophil recruitment but increased vascular permeability in vivo. J Exp Med (2011) 1.25
Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J Cell Mol Med (2009) 1.24
Expression of HOX genes in acute leukemia cell lines with and without MLL translocations. Leuk Lymphoma (2004) 1.22
The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood (2003) 1.22
Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification. Haematologica (2012) 1.20
Comparative antibiotic eradication of mycoplasma infections from continuous cell lines. In Vitro Cell Dev Biol Anim (2002) 1.16
Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia. J Histochem Cytochem (2002) 1.14
Match criteria for human cell line authentication: where do we draw the line? Int J Cancer (2012) 1.10
Detection of mycoplasma contaminations. Methods Mol Biol (2005) 1.10
SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines. J Hematol Oncol (2009) 1.09
Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1. Blood (2007) 1.09
Cell line cross-contamination initiative: an interactive reference database of STR profiles covering common cancer cell lines. Int J Cancer (2010) 1.09
Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia. Leuk Lymphoma (2009) 1.07
Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia. Haematologica (2011) 1.06
Authentication of scientific human cell lines: easy-to-use DNA fingerprinting. Methods Mol Biol (2005) 1.05
Authentication of cancer cell lines by DNA fingerprinting. Methods Mol Med (2004) 1.03
Cytogenetic harvesting of commonly used tumor cell lines. Nat Protoc (2007) 1.03
Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues. Int J Cancer (2004) 1.03
Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. J Biotechnol (2002) 1.02
Bladder carcinoma cell line ECV304 is not a model system for endothelial cells. In Vitro Cell Dev Biol Anim (2002) 1.02
Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2). Genes Chromosomes Cancer (2003) 1.01
Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid--an experimental study in rats. Biomaterials (2008) 1.01
Detecting mycoplasma contamination in cell cultures by polymerase chain reaction. Methods Mol Biol (2011) 1.00
Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2. Clin Cancer Res (2010) 0.99
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood (2014) 0.98
Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas. BMC Cancer (2007) 0.96
Polycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines. Mol Cancer (2010) 0.96
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms. J Transl Med (2011) 0.95
Online verification of human cell line identity by STR DNA typing. Methods Mol Biol (2011) 0.94
Mouse lung contains endothelial progenitors with high capacity to form blood and lymphatic vessels. BMC Cell Biol (2010) 0.94
The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: a study with 193 cases. Oncol Rep (2006) 0.93
Treatment of mycoplasma contamination in cell cultures with Plasmocin. J Biomed Biotechnol (2012) 0.93
Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia. Mol Cancer (2009) 0.93
Detecting Mycoplasma contamination in cell cultures by polymerase chain reaction. Methods Mol Med (2004) 0.93
Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines. J Biomed Biotechnol (2010) 0.93
Detection of p53 gene mutations by single strand conformational polymorphism (SSCP) in human acute myeloid leukemia-derived cell lines. Leuk Res (2002) 0.93
Activation of HLXB9 by juxtaposition with MYB via formation of t(6;7)(q23;q36) in an AML-M4 cell line (GDM-1). Genes Chromosomes Cancer (2005) 0.92
Embryonic development and malformation of lymphatic vessels. Novartis Found Symp (2007) 0.91
Identification and verification of rodent cell lines by polymerase chain reaction. Cytotechnology (2007) 0.90
Mantle cell lymphoma-derived cell lines: unique research tools. Leuk Res (2006) 0.89
Eradication of mycoplasma contaminations. Methods Mol Biol (2005) 0.89
Mycoplasma contamination of murine embryonic stem cells affects cell parameters, germline transmission and chimeric progeny. Transgenic Res (2008) 0.89
Elimination of mycoplasmas from infected cell lines using antibiotics. Methods Mol Biol (2011) 0.89
Tumor necrosis factor receptor-associated factor (TRAF) 4 is a new binding partner for the p70S6 serine/threonine kinase. Leuk Res (2003) 0.88
t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2. Genes Chromosomes Cancer (2011) 0.88
Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines. AIDS (2010) 0.88
The necessity of identity assessment of animal intestinal cell lines: A case report. Cytotechnology (2011) 0.88
A simple method using beta-globin polymerase chain reaction for the species identification of animal cell lines--a progress report. In Vitro Cell Dev Biol Anim (2004) 0.87
Public repositories: users reluctant to give materials. Nature (2006) 0.87
Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia. Leuk Lymphoma (2011) 0.86
STR DNA typing of human cell lines: detection of intra- and interspecies cross-contamination. Methods Mol Biol (2013) 0.86
Deregulated FOX genes in Hodgkin lymphoma. Genes Chromosomes Cancer (2014) 0.86
BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia. Cancer Genet Cytogenet (2004) 0.86
Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines. Leuk Res (2009) 0.86
BCR-ABL1 expression in multiple myeloma cells: a case of mistaken identity? Proc Natl Acad Sci U S A (2013) 0.85
Transcriptional deregulation of homeobox gene ZHX2 in Hodgkin lymphoma. Leuk Res (2011) 0.85
The Wnt pathway destabilizes adherens junctions and promotes cell migration via β-catenin and its target gene cyclin D1. FEBS Open Bio (2012) 0.84
Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt's lymphoma. Am J Pathol (2013) 0.84
Cytogenetic analysis of cancer cell lines. Methods Mol Biol (2011) 0.84
Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell lines. Blood Cells Mol Dis (2002) 0.84
VEGFR-3 is expressed on megakaryocyte precursors in the murine bone marrow and plays a regulatory role in megakaryopoiesis. Blood (2012) 0.84
Similarities and differences of human and experimental mouse lymphangiomas. Dev Dyn (2007) 0.84
De novo hem- and lymphangiogenesis by endothelial progenitor and mesenchymal stem cells in immunocompetent mice. Cell Mol Life Sci (2013) 0.83
t(8;9)(p22;p24)/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5. PLoS One (2013) 0.83
Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin. Leuk Res (2004) 0.83
Stable expression of MutLγ in human cells reveals no specific response to mismatched DNA, but distinct recruitment to damage sites. J Cell Biochem (2013) 0.83
Molecular cloning, expression, purification, and characterization of soluble full-length, human interleukin-3 with a baculovirus-insect cell expression system. Protein Expr Purif (2003) 0.82
High-resolution mass spectrometric analysis of the secretome from mouse lung endothelial progenitor cells. Angiogenesis (2011) 0.82
Activation of Paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia. Leuk Lymphoma (2011) 0.82
NK-like homeodomain proteins activate NOTCH3-signaling in leukemic T-cells. BMC Cancer (2009) 0.82
Development of an enzyme-linked immunoreceptor assay (ELIRA) for quantification of the biological activity of recombinant human bone morphogenetic protein-2. J Biotechnol (2005) 0.82